Aft Pharmaceuticals (ASX: AFP) — Company Overview, News & Financial Data
AFT Pharmaceuticals develops a broad portfolio of pharmaceutical products, including both proprietary and in-licensed drugs.
Aft Pharmaceuticals
Aft Pharmaceuticals is a New Zealand-based pharmaceutical company that develops, licenses, and commercializes proprietary and over-the-counter healthcare products globally. Founded in 1997, the company focuses on delivering therapeutic formulations across key categories including pain management, eyecare, dermatology, cold and flu, and prescription medicines. Its flagship patented pain relief formulation, Maxigesic, is distributed across multiple international markets. Aft Pharmaceuticals operates distribution networks across Australasia, Asia-Pacific, North America, Europe, and Africa, partnering with healthcare providers, retail pharmacies, and clinical networks to deliver prescription and non-prescription treatments.
Snapshot
Operations
Products and/or services of Aft Pharmaceuticals
- Patented Pain Management: Formulation and global distribution of patented dual-action pain relief products combining paracetamol and ibuprofen. Available in oral tablets, intravenous, liquid, and hot drink formats across international pharmaceutical markets in Australasia, Europe, the Americas, and Asia.
- Over-the-Counter Healthcare: Non-prescription consumer health products covering pain relief, allergy care, cold and flu remedies, and gastrointestinal treatments. Distributed through retail pharmacy channels, supermarkets, and online platforms across New Zealand, Australia, and select export markets.
- Prescription Pharmaceuticals: Development and marketing of branded and generic prescription medications across diverse therapeutic categories, including cardiovascular health, pain management, dermatology, oncology, and central nervous system disorders supplied directly to healthcare professionals and hospital pharmacy networks.
- Hospital and Critical Care Products: Specialized injectable pharmaceuticals, critical care medications, and hospital-grade therapies supplied to public health authorities and private clinical facilities across Australasian markets, supporting inpatient surgical, emergency, and specialized therapeutic treatment regimens.
- Ophthalmic and Eyecare Range: Specialized eye care treatments including preservative-free lubricating drops, dry eye therapies, and anti-inflammatory ophthalmic formulations distributed to eye clinics, optometrists, and retail pharmacies across regional and international distribution networks.
- Dermatology and Skincare Therapies: Topical dermatological treatments, antibacterial creams, and specialized skin care products designed for infection management and wound care, distributed through community pharmacies, medical practices, and healthcare distribution channels across global markets.
Aft Pharmaceuticals executive team
- Hartley AtkinsonCo-Founder, CEO, MD & Executive Director
- Marree AtkinsonCo-Founder, Chief of Staff & Executive Director
- Stuart D. HoulistonChief Financial Officer
- Ioana StanescuChief Scientific Officer
- Murray KeithGroup Marketing Manager